Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Gulseren Aktas


Gulseren Aktas

Istanbul University, Turkey

Biography

Because multi-drug resistant Gram-positive bacteria have been isolated frequently worldwide and have difficulties in the treatment, development of new antibiotics and alternative treatment choices are required. Combination antibiotherapies have a distinct advantage over monotherapies in terms of their broad spectrum and synergistic effect. Antibiotic combinations are sometimes in an attempt to prevent or delay the in vivo emergence of drug-resistant subpopulations of pathogenic organisms. In the present study, it was aimed to investigate the in vitro activity of linezolid and dalbavancin in combination with vancomycin against clinical VRE strains.

Abstract

Abstract : Activity of Vancomycin Combined with Linezolid and with Dalbavancin against Clinical VRE Strains